PHARMACY

PhRMA adds Genentech, Gilead Sciences to membership roster
With the addition of the two members, the Pharmaceutical Research and Manufacturers of America's membership now comprises the top 20 biopharmaceutical companies.
FDA chief: Agency has money for about 5 more weeks of drug approvals
FDA commissioner Scott Gottlieb responded to queries about the government shutdown's effect on drug approvals on Twitter.

FDA approves new Cabometyx indication

FDA's approval of a new Cabometyx indication provides a treatment for patients with liver cancer.
Walmart will remain in certain CVS Caremark Rx networks

Walmart will continue to participate in CVS Caremark's PBM commercial and Managed Medicaid retail pharmacy networks, as well as Medicare Part D networks.
Albertsons to use PQS's EQuIPP Analytics

Albertsons has chosen Pharmacy Quality Solutions' EQuIPP Analytics for enhanced reporting capabilities.
Vitruvius Therapeutics gets FDA nod for vitamin B-12 injection

Vitruvius Therapeutics has received the FDA's blessing for its vitamin B-12 injection, which had a market value of roughly $74.3 million for the year ended September 2018.
Nexus Pharmaceuticals gets FDA OK for generic Busulfex injection

Nexus Pharmaceuticals' generic Busulfex is the company's second oncology generic drug.
Shopko files for Chapter 11 protection, will auction Rx business

In addition to optioning its pharmacy business during the Chapter 11 process, Shopko said it would be closing 38 stores and relocating 20 optical centers to freestanding locations.
Teva gets FDA green light for first generic Sabril

Teva has received the Food and Drug Administration's approval for the first generic of Lundbeck's Sabril.
AAM joins newly formed Coalition Against Patent Abuse

The Association for Accessible Medicines has joined the Coalition Against Patent Abuse, a new stakeholder association that is focused on fighting abuses of the patent system.